0001171843-16-010579.txt : 20160608 0001171843-16-010579.hdr.sgml : 20160608 20160608211411 ACCESSION NUMBER: 0001171843-16-010579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160606 FILED AS OF DATE: 20160608 DATE AS OF CHANGE: 20160608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L CENTRAL INDEX KEY: 0001202016 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 161704805 MAIL ADDRESS: STREET 1: C/O XIMMUNOMEDICS INC STREET 2: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN CYNTHIA L DATE OF NAME CHANGE: 20021029 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2016-06-06 0 0000722830 IMMUNOMEDICS INC IMMU 0001202016 GOLDENBERG CYNTHIA L C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 President and CEO Common Stock 2016-06-06 4 M 0 63959 2.50 A 703029 D Common Stock 2016-06-06 4 S 0 63959 4.0945 D 639070 D Common Stock 2016-06-06 4 M 0 110322 2.50 A 5345784 I See footnote Common Stock 2016-06-06 4 S 0 110322 4.0881 D 5235462 I See footnote Common Stock 2016-06-07 4 M 0 4600 2.50 A 643670 D Common Stock 2016-06-07 4 S 0 4600 4.0059 D 639070 D Common Stock 2016-06-07 4 M 0 12300 2.50 A 5247762 I See footnote Common Stock 2016-06-07 4 S 0 12300 3.98 D 5235462 I See footnote Common Stock 2016-06-08 4 M 0 31441 2.50 A 670511 D Common Stock 2016-06-08 4 M 0 10000 2.63 A 680511 D Common Stock 2016-06-08 4 S 0 41441 3.6249 D 639070 D Common Stock 2016-06-08 4 M 0 120388 2.50 A 5355850 I See footnote Common Stock 2016-06-08 4 S 0 120388 3.6447 D 5235462 I See footnote Stock Option (right to buy) 2.50 2016-06-06 4 M 0 63959 0 D 2016-06-10 Common Stock, par value $0.01 per share 63959 36041 D Stock Option (right to buy) 2.50 2016-06-06 4 M 0 110322 0 D 2016-06-10 Common Stock, par value $0.01 per share 110322 214678 I See footnote Stock Option (right to buy) 2.50 2016-06-07 4 M 0 4600 0 D 2016-06-10 Common Stock, par value $0.01 per share 4600 31441 D Stock Option (right to buy) 2.50 2016-06-07 4 M 0 12300 0 D 2016-06-10 Common Stock, par value $0.01 per share 12300 202378 I See footnote Stock Option (right to buy) 2.50 2016-06-08 4 M 0 31441 0 D 2016-06-10 Common Stock, par value $0.01 per share 31441 0 D Stock Option (right to buy) 2.63 2016-06-08 4 M 0 10000 0 D 2016-06-14 Common Stock, par value $0.01 per share 10000 140000 D Stock Option (right to buy) 2.50 2016-06-08 4 M 0 120388 0 D 2016-06-10 Common Stock, par value $0.01 per share 120388 81990 I See footnote Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Medical Officer and Chairman of the Board of Directors. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.00 to $4.45. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein. The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.00 to $4.02. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.96 to $4.02. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.6041 to $3.67. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.6041 to $3.685. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan. These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year. /s/ Cynthia L. Goldenberg 2016-06-08